Onconova Therapeutics (NASDAQ:ONTX) Research Coverage Starte

Analysts at StockNews.com initiated coverage on shares of Onconova Therapeutics (NASDAQ:ONTX – Get Free Report) in a research note issued on Sunday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Onconova Therapeutics Trading Down 1.0 % Shares of ONTX opened at $1.00 on Friday. Onconova Therapeutics has a twelve month low of […]

Related Keywords

United States , , Onconova Therapeutics Company Profile , Vanguard Group Inc , Beacon Pointe Advisors , Onconova Therapeutics Inc , Renaissance Technologies , Millennium Management , Onconova Therapeutics , Get Free Report , Therapeutics Trading Down , Pointe Advisors , Vanguard Group , Onconova Therapeutics Daily , Nasdaq Ontx , Contx , Medical , Initiated Coverage , Stocknews Com ,